Ticker Symbol | Entity Name | As Of Date | Company Name | Followers | Employees on Linkedin | Link | Industry | Date Added | Date Updated | Description | Website | Specialities | Logo | HQ.Street | HQ.City | HQ.State | HQ.Country | HQ.Postal | Headcount change in past 24 months | Company Name | Sector | Industry |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
private:ischemix | 267229 | May 29th, 2019 12:00AM | Ischemix | 88 | 7.00 | Open | Biotechnology | May 29th, 2019 01:48AM | May 29th, 2019 01:48AM | Ischemix is a privately-held pharmaceutical company that has developed novel cytoprotective compounds for the prevention and treatment of serious conditions of the kidney, heart and other organ systems. | Open | Open | Great Road | Maynard | MA | US | 01754 | Ischemix | Pharmaceuticals & Biotechnology | |||
private:ischemix | 267229 | Mar 9th, 2018 12:00AM | Ischemix | 78 | 7.00 | Open | Biotechnology | Mar 9th, 2018 06:45PM | Mar 9th, 2018 06:45PM | Open | Ischemix | Pharmaceuticals & Biotechnology | ||||||||||
private:ischemix | 267229 | Feb 17th, 2018 12:00AM | Ischemix | 77 | 7.00 | Open | Biotechnology | Feb 17th, 2018 02:25PM | Feb 17th, 2018 02:25PM | Ischemix is a privately-held pharmaceutical company that has developed novel cytoprotective compounds for the prevention and treatment of serious conditions of the kidney, heart and other organ systems. | Ischemix | Pharmaceuticals & Biotechnology | ||||||||||
private:ischemix | 267229 | Feb 16th, 2018 12:00AM | Ischemix | 77 | 7.00 | Open | Biotechnology | Feb 16th, 2017 08:15AM | Feb 16th, 2017 08:15AM | Ischemix is a privately-held pharmaceutical company that has developed novel cytoprotective compounds for the prevention and treatment of serious conditions of the kidney, heart and other organ systems. | Ischemix | Pharmaceuticals & Biotechnology | ||||||||||
private:ischemix | 267229 | Feb 15th, 2018 12:00AM | Ischemix | 77 | 7.00 | Open | Biotechnology | Feb 15th, 2017 10:07AM | Feb 15th, 2017 10:07AM | Ischemix is a privately-held pharmaceutical company that has developed novel cytoprotective compounds for the prevention and treatment of serious conditions of the kidney, heart and other organ systems. | Ischemix | Pharmaceuticals & Biotechnology | ||||||||||
private:ischemix | 267229 | Feb 14th, 2018 12:00AM | Ischemix | 77 | 7.00 | Open | Biotechnology | Feb 14th, 2017 01:50PM | Feb 14th, 2017 01:50PM | Ischemix is a privately-held pharmaceutical company that has developed novel cytoprotective compounds for the prevention and treatment of serious conditions of the kidney, heart and other organ systems. | Ischemix | Pharmaceuticals & Biotechnology | ||||||||||
private:ischemix | 267229 | Feb 13th, 2018 12:00AM | Ischemix | 77 | 7.00 | Open | Biotechnology | Feb 13th, 2017 04:11PM | Feb 13th, 2017 04:11PM | Ischemix is a privately-held pharmaceutical company that has developed novel cytoprotective compounds for the prevention and treatment of serious conditions of the kidney, heart and other organ systems. | Ischemix | Pharmaceuticals & Biotechnology | ||||||||||
private:ischemix | 267229 | Feb 12th, 2018 12:00AM | Ischemix | 77 | 7.00 | Open | Biotechnology | Feb 12th, 2017 04:15AM | Feb 12th, 2017 04:15AM | Ischemix is a privately-held pharmaceutical company that has developed novel cytoprotective compounds for the prevention and treatment of serious conditions of the kidney, heart and other organ systems. | Ischemix | Pharmaceuticals & Biotechnology | ||||||||||
private:ischemix | 267229 | Feb 11th, 2018 12:00AM | Ischemix | 77 | 7.00 | Open | Biotechnology | Feb 11th, 2017 05:35AM | Feb 11th, 2017 05:35AM | Ischemix is a privately-held pharmaceutical company that has developed novel cytoprotective compounds for the prevention and treatment of serious conditions of the kidney, heart and other organ systems. | Ischemix | Pharmaceuticals & Biotechnology | ||||||||||
private:ischemix | 267229 | Feb 10th, 2018 12:00AM | Ischemix | 77 | 7.00 | Open | Biotechnology | Feb 10th, 2017 06:43AM | Feb 10th, 2017 06:43AM | Ischemix is a privately-held pharmaceutical company that has developed novel cytoprotective compounds for the prevention and treatment of serious conditions of the kidney, heart and other organ systems. | Ischemix | Pharmaceuticals & Biotechnology |